The CD8+PD-1+/CD4+PD-1+ index proposed in this previous study was based on the premise that high CD8+PD-1+ T cell levels are associated with good prognosis in cancer patients, whereas high CD4+PD-1+ T cell levels are associated with poor clinical outcomes. This evidence concerns the gene CD4 and cancer.